FDA Rethinking Automatic 30-Month Stay in Patent Thickets After Endo Sues

A new chapter emerged this week in the contentious issue of patent thickets, a web of overlapping patents filed on a single existing product to create barriers to competition and extend effective patent life.
Source: Drug Industry Daily